semaglutide training course online free Weight Loss for Doctors, NP's and Nurses. CME-accredited Semaglutide Masterclass for Healthcare Providers

Amgen Inc

In todays newsletter: A new study shows that people dont just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse leading to questions about long-term impacts and solutions

Listed on Oct 17, 2024 | Patient, Peptide therapy, Fat loss

Retatrutide is a multi-pathway metabolic agonist studied for combined engagement of GLP-1, GIP, and glucagon receptors, positioning it for comprehen

Members of $MED's Scientific and Clinical Affairs team and Medifasts Scientific Advisory Board recently published an article in Diabetes, Obesity and Metabolism, highlighting GLP-1 discontinuation rates